Scott is a partner with significant first-chair trial and appeal experience in the pharmaceutical and information technology sectors, including at the Supreme Court of Canada. For more than 20 years, he has a proven track record in high-stakes litigation under the Patented Medicines (Notice of Compliance) Regulations. For his pharmaceutical clients, Scott has also developed and successfully implemented many novel patent and regulatory strategies, including acting as lead counsel on one of the first successful pharmaceutical summary trials that invalidated patent claims on a blockbuster erectile dysfunction drug.
Scott’s client-centric approach was shaped by his prior in-house counsel experience at a large Canadian generic drug manufacturer. Scott strives to always obtain the best client result in the most efficient manner for all patent, trademark and copyright matters.
Scott is also a registered Canadian patent and trademark agent and maintains a procurement practice on behalf clients in a wide variety of technical areas.
Prior to becoming a lawyer, Scott obtained an Ph.D. in biology from the University of Utah.